Ignite Creation Date:
2025-12-25 @ 12:27 AM
Ignite Modification Date:
2026-06-02 @ 6:44 PM
Study NCT ID:
NCT03509467
Status:
COMPLETED
Last Update Posted:
2025-12-19
First Post:
2018-04-17
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Using MC1R Genotype to Impact Melanoma Risk Behavior
Sponsor:
H. Lee Moffitt Cancer Center and Research Institute
Organization:
Study Overview
Official Title:
Using MC1R Genotype to Impact Melanoma Risk Behavior
Status:
COMPLETED
Status Verified Date:
2025-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to examine how different messages about risk of melanoma can impact the way people protect themselves against developing these diseases.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
Secondary ID Infos
| Secondary ID | Type | Domain | Link | View |
|---|---|---|---|---|
| MCC-19461 | OTHER | H. Lee Moffitt Cancer and Research Center | View |